SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nectar Lifesciences - Quaterly Results

13 Nov 2021 Evaluate
Net sales declined -14.77%  to  Rs. 3645.70 million from Rs. 4277.29 millions.The Total Profit for the quarter ended September 2021 of Rs. 18.62 millions grew from Rs.-73.08 millionsOP of the company witnessed a marginal growth to 325.55 millions from 320.08 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 3645.70 4277.29 -14.77 7490.23 8161.61 -8.23 15428.96 23631.57 -34.71
Other Income 50.97 5.30 861.70 102.43 10.48 877.39 27.22 40.06 -32.05
PBIDT 325.55 320.08 1.71 733.42 492.60 48.89 1129.49 2223.33 -49.20
Interest 180.09 278.84 -35.41 437.54 557.53 -21.52 1120.32 1258.23 -10.96
PBDT 145.46 41.24 252.72 295.88 -64.93 -555.69 -243.98 965.10 -125.28
Depreciation 141.54 150.93 -6.22 284.32 301.44 -5.68 602.53 607.66 -0.84
PBT 3.92 -109.69 -103.57 11.56 -366.37 -103.16 -846.51 357.44 -336.83
TAX -14.70 -36.61 -59.85 -27.75 -125.05 -77.81 -115.04 56.83 -302.43
Deferred Tax -14.70 -36.61 -59.85 -27.75 -125.05 -77.81 -200.90 40.21 -599.63
PAT 18.62 -73.08 -125.48 39.31 -241.32 -116.29 -731.47 300.61 -343.33
Equity 224.26 224.26 0.00 224.26 224.26 0.00 224.26 224.26 0.00
PBIDTM(%) 7.75 6.55 18.27 9.79 6.04 62.23 6.41 8.42 -23.95

Nectar Lifesciences Share Price

12.50 0.24 (1.96%)
16-Apr-2026 11:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.60
Dr. Reddys Lab 1220.80
Cipla 1231.95
Zydus Lifesciences 938.60
Lupin 2307.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×